Publications by authors named "Macklin G Loveland"
Circ Heart Fail
November 2022
Article Synopsis
- Angiotensin receptor-neprilysin inhibitor (ARNI) prescriptions in the U.S. for heart failure patients are low despite evidence of their benefits; economic factors may hinder access for some individuals.
- An analysis of over 136,000 patients revealed that a small percentage (12.6%) received an ARNI at discharge, with previous ARNI use and insurance status being significant predictors of prescription rates.
- There’s a growing trend in ARNI prescriptions over time; however, the gap between rates in distressed versus affluent communities is widening, indicating ongoing disparities in healthcare access.
